Sandbox: DDx 2: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 89: Line 89:
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Symptoms'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Symptoms'''}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Diaphoresis'''
'''Diaphoresis'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 98: Line 98:
Absent
Absent
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Watery diarrhea'''
'''Watery diarrhea'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 107: Line 107:
Absent
Absent
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Heartburn'''
'''Heartburn'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 118: Line 118:
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Lab values'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Lab values'''}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Hypoglycemia'''
'''Hypoglycemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 127: Line 127:
Absent
Absent
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Hypokalemia'''
'''Hypokalemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 136: Line 136:
Absent
Absent
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''Hypergastrinemia'''
'''Hypergastrinemia'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 147: Line 147:
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Imaging'''}}
! style="background: #8f8990; width: 150px;" | {{fontcolor|#FFF|'''Imaging'''}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''CT Scan'''
'''CT Scan'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Line 157: Line 157:
|-
|-
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center|
'''MRI'''
'''MRI'''
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
T1 C+ (Gd) typically shows enhancement
T2-weighted, increased-signal intensity mass
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Hypervascularity with diffuse multiple metastatic nodulation
T1-weighted, decreased-signal-intensity masses
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
| style="padding: 5px 5px; background: #F5F5F5;" align=center|
Small hypoattenuating nodule ± calcification
T1-weighted, decreased-signal intensity masses
|-
|-
| style="padding: 5px 5px; background: #8f8990; font-weight: bold" align=center |{{fontcolor|#FFF|
| style="padding: 5px 5px; background: #8f8990; font-weight: bold" align=center |{{fontcolor|#FFF|

Latest revision as of 02:12, 22 October 2015

DDX 1

Differential Diagnosis Key Symptoms Characteristic Lab Findings CT Scan Characteristic Histopathological Features

Insulinoma

  • Diaphoresis
  • Tremor
  • Palpitations
  • Seizures
  • Coma
  • Hypoglycemia
  • Hyperinsulinemia
  • Elevated C-peptide level
  • Elevated Pro-insulin level
  • Calcification and hyperattenuation of the mass
  • Solid or gyriform cellular patterns
  • Amyloid deposition
  • Nesidioblastosis may be present
  • Absence of glands

VIPoma

  • Watery diarrhea
  • Dehydration
  • Lethargy
  • Muscle weakness
  • Flushing
  • Elevated (VIP) levels
  • Elevated neurotensin levels
  • Hypokalemia
  • Hypomagnesaemia
  • Hypercalcaemia
  • Metabolic acidosis
  • Hypervascularity with diffuse multiple metastatic nodulation
  • Solid sheets
  • Uniform cuboidal cells
  • Centrally located nuclei
  • Stippled chromatin
  • Granular eosinophilic cytoplasm

Gastrinoma

  • Epigastric abdominal pain
  • Diarrhea
  • Heartburn
  • Hematemesis
  • Elevated serum gastrin level
  • Positive secretin stimulation test
  • Small hypoattenuating nodule ± calcification
  • Lobular-trabecular pattern
  • Gastrin+ tumor cells
  • Infiltration of Brunner glands

DDX 2

Characteristics Insulinoma Vipoma Gastrinoma
Symptoms

Diaphoresis

Present

Absent

Absent

Watery diarrhea

Absent

Present

Absent

Heartburn

Absent

Absent

Present

Lab values

Hypoglycemia

Present

Absent

Absent

Hypokalemia

Absent

Present

Absent

Hypergastrinemia

Absent

Absent

Present

Imaging

CT Scan

Calcification and hyperattenuation of the mass

Hypervascularity with diffuse multiple metastatic nodulation

Small hypoattenuating nodule ± calcification

MRI

T2-weighted, increased-signal intensity mass

T1-weighted, decreased-signal-intensity masses

T1-weighted, decreased-signal intensity masses

Histopathology

Solid or gyriform cellular patterns with amyloid deposition, absence of glands, and nesidioblastosis

Solid sheets with uniform cuboidal cells, centrally located nuclei, and granular cytoplasm

Lobular-trabecular pattern of gastrin positive tumor cells with infiltration of Brunner glands